Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn J Barst

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Current Opinion in Pediatrics|May 14, 2005
Idiopathic pulmonary arterial hypertension in childrenErika Berman Rosenzweig, Robyn J Barst
Treatments in Respiratory Medicine|March 4, 2006
Pulmonary arterial hypertension : a comprehensive review of pharmacological treatmentErika Berman Rosenzweig, Robyn J Barst
Progress in Cardiovascular Diseases|September 27, 2012
Congenital heart disease and pulmonary hypertension: pharmacology and feasibility of late surgeryErika B Rosenzweig, Robyn J Barst
Current Opinion in Pediatrics|May 14, 2008
Pulmonary arterial hypertension in children: a medical updateErika B Rosenzweig, Robyn J Barst
Progress in Cardiovascular Diseases|November 2, 2002
Eisenmenger's syndrome: current managementErika Berman Berman, Robyn J Barst
Expert Review of Cardiovascular Therapy|November 19, 2005
Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertensionAllison C Widlitz, Robyn J Barst, Evelyn M Horn
Pediatric Pulmonology|June 2, 2004
Pulmonary arterial hypertension in childrenErika Berman Rosenzweig, Allison C Widlitz, Robyn J Barst
Pulmonary Circulation|July 28, 2012
Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertensionRobyn J Barst, Richard Channick, Dunbar Ivy, et al.
Expert Opinion on Investigational Drugs|October 27, 2004
Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertensionEvelyn M Horn, Allison C Widlitz, Robyn J Barst
Cardiology in the Young|September 18, 2007
The effect of atrial septostomy on the concentration of brain-type natriuretic peptide in patients with idiopathic pulmonary arterial hypertensionMichael L O'Byrne, Erika S Berman Rosenzweig, Robyn J Barst
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Current Opinion in Pediatrics|May 14, 2005
Idiopathic pulmonary arterial hypertension in childrenErika Berman Rosenzweig, Robyn J Barst
Treatments in Respiratory Medicine|March 4, 2006
Pulmonary arterial hypertension : a comprehensive review of pharmacological treatmentErika Berman Rosenzweig, Robyn J Barst
Progress in Cardiovascular Diseases|September 27, 2012
Congenital heart disease and pulmonary hypertension: pharmacology and feasibility of late surgeryErika B Rosenzweig, Robyn J Barst
Current Opinion in Pediatrics|May 14, 2008
Pulmonary arterial hypertension in children: a medical updateErika B Rosenzweig, Robyn J Barst
Progress in Cardiovascular Diseases|November 2, 2002
Eisenmenger's syndrome: current managementErika Berman Berman, Robyn J Barst
Expert Review of Cardiovascular Therapy|November 19, 2005
Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertensionAllison C Widlitz, Robyn J Barst, Evelyn M Horn
Pediatric Pulmonology|June 2, 2004
Pulmonary arterial hypertension in childrenErika Berman Rosenzweig, Allison C Widlitz, Robyn J Barst
Pulmonary Circulation|July 28, 2012
Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertensionRobyn J Barst, Richard Channick, Dunbar Ivy, et al.
Expert Opinion on Investigational Drugs|October 27, 2004
Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertensionEvelyn M Horn, Allison C Widlitz, Robyn J Barst
Cardiology in the Young|September 18, 2007
The effect of atrial septostomy on the concentration of brain-type natriuretic peptide in patients with idiopathic pulmonary arterial hypertensionMichael L O'Byrne, Erika S Berman Rosenzweig, Robyn J Barst
Pageof 14